Gilead CAR-T Joins Billion-Dollar Club As Biktarvy Sales Cross $10bn Mark

Veklury Declines As COVID-19 Demand Eases

 
• By Alaric DeArment
Gilead Sciences announced its Q4 and FY 2022 earnings on 2 February • Source: Shutterstock

More from Earnings

More from Business